Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial

NCT03104335 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Not enough patients

Conditions

Soft Tissue Sarcoma Adult
Advanced Cancer

Interventions

DRUG: Apatinib

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]